Zobrazeno 1 - 6
of 6
pro vyhledávání: '"John M. Skaugen"'
Autor:
Taylor A. Gatesman, Jasmine L. Hect, H. Westley Phillips, Brenden J. Johnson, Abigail I. Wald, Colleen McClung, Marina N. Nikiforova, John M. Skaugen, Ian F. Pollack, Taylor J. Abel, Sameer Agnihotri
Publikováno v:
Epilepsia Open, Vol 9, Iss 1, Pp 409-416 (2024)
Abstract Low‐grade epilepsy‐associated tumors (LEATs) are a common cause of drug‐resistant epilepsy in children. Herein, we demonstrate the feasibility of using tumor tissue derived from stereoelectroencephalography (sEEG) electrodes upon remov
Externí odkaz:
https://doaj.org/article/1dc2e131ba0d4201ad3038e3090ca6f5
Publikováno v:
American Journal of Clinical Pathology. 159:211-220
Objectives Epithelioid angiomyolipoma (EAML, perivascular epithelioid cell tumor) is an uncommon primary renal tumor that may recur or metastasize, although there remain limited data for prediction of these outcomes. Here, we report two cases of rena
Autor:
John M. Skaugen, Charit Taneja, Jason B. Liu, Abigail I. Wald, Alyaksandr V. Nikitski, Simion I. Chiosea, Raja R. Seethala, N. Paul Ohori, Esra Karslioglu-French, Sally E. Carty, Marina N. Nikiforova, Linwah Yip, Yuri E. Nikiforov
Publikováno v:
Thyroid. 32:1500-1508
Publikováno v:
Cancer Cytopathology. 129:104-113
Background Acinic cell carcinoma (AcCC) is diagnostically challenging on fine-needle aspiration because it can mimic several other neoplasms or even normal acinar tissue. Immunopositivity for DOG1, especially circumferential membranous staining, can
Autor:
Andrea L. Cortese Hassett, Jansen N. Seheult, Michael P. Meyer, John M Skaugen, Franklin A. Bontempo, Irina Chibisov, Christine Sayre
Publikováno v:
American journal of clinical pathology. 157(3)
Objectives This study established the performance characteristics of DOAC-Remove for neutralization of the effects of rivaroxaban and apixaban in lupus anticoagulant (LAC) testing. Methods Normal donor, LAC control, and patient samples were spiked wi
Autor:
John M Skaugen, Kenichi Tamama, Spiros Giannoutsos, Matthew D. Krasowski, Anthony Scoccimarro, Anthony F. Pizon, Sean Ekins, Jacqueline A. Rymer
Publikováno v:
Annals of clinical biochemistry. 56(5)
Background Immunoassays are commonly used to test for drugs of abuse in patients in a variety of settings. The increasing prevalence of ‘designer’ drugs causes difficulties for the toxicology laboratory and may result in unexpected false positive